Prof. Dr. SEVİM BAVBEK, Ankara University, Turkey
Prof. Dr. Sevim Bavbek is a renowned Clinical Professor and Head of the Department of Clinical Immunology and Allergy at Ankara University Medical School, with a distinguished career in allergy and pulmonology. She completed her education and training at Ankara University, Medical School, where she also undertook her pulmonology residency and allergy fellowship. Prof. Dr. Bavbek has made significant contributions to the field of allergy and immunology, particularly in NSAID hypersensitivity, asthma, and atopic dermatitis. Her international collaborations with experts like Prof. Dr. Thomas Platts-Mills and Prof. Dr. Andrew Szczeklik further solidify her position as a key figure in clinical research. Prof. Dr. Bavbek has published over 200 peer-reviewed articles and serves on the editorial boards of several esteemed journals. She is also an active member of multiple prestigious professional societies, including the European Academy of Allergy and Clinical Immunology (EAACI) and the Turkish National Society of Allergy and Clinical Immunology.
Profile
Google Scholar
Education
Prof. Dr. Sevim Bavbek graduated from Ankara University Medical School, where she laid the foundation for her exceptional career in clinical immunology and allergy. Her academic journey continued with a pulmonology residency and allergy fellowship at the same institution, further enhancing her clinical expertise. During her early career, Prof. Dr. Bavbek broadened her international experience by working as a research associate at the University of Virginia Medical Center between 1995 and 1996, collaborating with distinguished researchers like Prof. Dr. Thomas Platts-Mills and Prof. Dr. Martin D. Chapman. This formative period allowed her to explore advanced topics in atopic dermatitis, antigen measurements in house dust, and recombinant allergens, significantly contributing to her understanding of allergic diseases. Her deep academic foundation and clinical training have been the cornerstone of her distinguished career as a professor and leader in the field of allergy and immunology.
Experience
Prof. Dr. Sevim Bavbek has built a distinguished career in clinical immunology and allergy, serving as a Clinical Professor and Head of the Department of Clinical Immunology and Allergy at Ankara University Medical School. With an impressive academic and clinical background, she has collaborated with leading experts in the field of allergy and pulmonology. Her research work includes a notable period as a research associate at the University of Virginia Medical Center (1995-1996), where she focused on atopic dermatitis, antigen measurements in house dust samples, and recombinant allergens. Additionally, in 2003, Prof. Dr. Bavbek worked with Prof. Dr. Andrew Szczeklik in Poland, conducting oral aspirin provocation tests. Throughout her career, she has been a board member of multiple prestigious societies, including the Turkish National Society of Allergy and Clinical Immunology, the European Academy of Allergy and Clinical Immunology, and the Drug Allergy Interest Group. Her work continues to impact both clinical practice and research globally.
Awards and Honors
Prof. Dr. Sevim Bavbek has received multiple awards and honors throughout her career, reflecting her exceptional contributions to the fields of allergy, immunology, and pulmonology. She has earned 30 poster and research awards at national society meetings, underscoring her commitment to advancing scientific understanding in her field. Prof. Dr. Bavbek’s scholarly work has been highly cited, with 203 peer-reviewed articles and an impressive H-index of 32, highlighting the widespread impact of her research. She has been recognized for her work on NSAID hypersensitivity, asthma, and drug allergies, publishing significant papers, including key position statements from the European Academy of Allergy and Clinical Immunology (EAACI). Her leadership roles, including serving as a board member of the Biological Working Group (2013-2019) and Drug Allergy Interest Group (since 2022), further demonstrate her influence and dedication to shaping the future of allergy research and clinical practice.
Research Focus
Prof. Dr. Sevim Bavbek’s primary research focus lies in the diagnosis and management of NSAID hypersensitivity, asthma, drug allergies, and atopic dermatitis. She has played a pivotal role in establishing clinical guidelines for managing NSAID-induced respiratory diseases (N-ERD), making significant contributions to position papers for the European Academy of Allergy and Clinical Immunology (EAACI). Prof. Dr. Bavbek’s work also delves into biologics for allergic disorders and their application in treating severe asthma and other complex allergic conditions. Her research on specific IgE and its relevance in diagnosing fungal and dust mite allergens in atopic dermatitis has been groundbreaking. Additionally, she has contributed extensively to the safety and efficacy of treatments like benralizumab and tezepelumab in severe asthma. Her continued research into improving patient care in allergy and clinical immunology has solidified her as a leading figure in her field, driving forward both scientific discovery and clinical advancements.
Publication Top Notes
-
Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti‐inflammatory drugs
Allergy 68 (10), 1219-1232
Cited by: 643 (2013)
Summary: This paper discusses the various types of hypersensitivity reactions to NSAIDs, providing a structured approach to diagnosis and management based on clinical and laboratory findings.
-
Hypersensitivity to nonsteroidal anti‐inflammatory drugs (NSAIDs) – classification, diagnosis and management: review of the EAACI/ENDA and GA2LEN/HANNA
Allergy 66 (7), 818-829
Cited by: 602 (2011)
Summary: A review highlighting the classification, diagnosis, and management strategies for NSAID hypersensitivity, providing valuable guidelines for clinical practice.
-
Diagnosis and management of NSAID‐Exacerbated Respiratory Disease (N‐ERD)—a EAACI position paper
Allergy 74 (1), 28-39
Cited by: 409 (2019)
Summary: This position paper provides comprehensive guidance on diagnosing and managing N-ERD, emphasizing the importance of identifying risk factors and optimizing treatment strategies.
-
Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial
The Lancet Respiratory Medicine 7 (1), 46-59
Cited by: 327 (2019)
Summary: A clinical trial reporting the long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma, confirming its beneficial role in asthma management.
Conclusion
Prof. Dr. Sevim Bavbek is an outstanding candidate for the Best Researcher Award, with an impressive portfolio of contributions that have significantly shaped the fields of allergy and clinical immunology. Her extensive research, leadership roles, and international collaborations highlight her as a trailblazer in her field. She has the academic rigor, clinical relevance, and professional engagement required for this award. By expanding her outreach to the public and exploring new areas of research, Prof. Dr. Bavbek has the potential to further elevate her already exceptional career. Her work not only impacts her field but also contributes to the betterment of patient care and the advancement of clinical practices worldwide.